Ixempra

Drug R-Pharm US LLC
Total Payments
$116,172
Transactions
1,126
Doctors
665
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $588.45 7 7
2019 $72,421 110 44
2018 $8,442 183 162
2017 $34,721 826 533

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $72,300 45 62.2%
Food and Beverage $26,454 1,030 22.8%
Travel and Lodging $17,418 51 15.0%

Top Doctors Receiving Payments for Ixempra — Page 27

Doctor Specialty Location Total Records
, MD Medical Oncology Glendale, AZ $11.05 1
, D.O Specialist Glendale, AZ $11.05 1
, M.D Medical Oncology Glendale, AZ $11.05 1
, M.D Internal Medicine Glendale, AZ $11.05 1
, M.D Specialist Glendale, AZ $11.05 1
, MD Gynecologic Oncology Austin, TX $11.03 1
, MD Hematology & Oncology Austin, TX $11.02 1
, MD Medical Oncology Houston, TX $10.82 1
, MD Hematology & Oncology Voorhees, NJ $10.69 1
, MD Medical Oncology Saint Louis, MO $10.69 1
, MD Radiation Oncology Fayetteville, AR $10.65 1
, M.D Hematology & Oncology Jefferson Hills, PA $10.55 1
, M.D Internal Medicine Pittsburgh, PA $10.55 1
, MD Otolaryngology Bethel Park, PA $10.55 1
, MD Hematology & Oncology Butler, PA $10.52 1
, MD Hematology & Oncology Butler, PA $10.52 1

About Ixempra

Ixempra is a drug associated with $116,172 in payments to 665 healthcare providers, recorded across 1,126 transactions in the CMS Open Payments database. The primary manufacturer is R-Pharm US LLC.

Payment data is available from 2017 to 2024. In 2024, $588.45 was paid across 7 transactions to 7 doctors.

The most common payment nature for Ixempra is "Consulting Fee" ($72,300, 62.2% of total).